Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment
CompletedOBSERVATIONAL
Enrollment
400
Participants
Timeline
Start Date
March 1, 2020
Primary Completion Date
December 1, 2022
Study Completion Date
April 1, 2023
Conditions
Multiple Sclerosis
Trial Locations (1)
1820
Nationaal MS center, Melsbroek
All Listed Sponsors
lead
National MS Center Melsbroek
OTHER
NCT05834335 - Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment | Biotech Hunter | Biotech Hunter